Image

    A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma

    January 2004 in “ Dermatology ”
    B. Guillot, Lorena Blázquez, Didier Bessis … J J Guilhou
    Studysummary This study found that 87% of patients with stage IIA and IIB melanoma treated with low-dose alpha-interferon reported cutaneous side effects, with the most common being hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on karger.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Straight Hair Associated with Interferon-Alpha Plus Ribavirin in Hepatitis C Infection British Journal of Dermatology · 2002
    2. Cutaneous Reactions to Recombinant Cytokine Therapy Journal of The American Academy of Dermatology · 1995